Home
Investment Rounds
Abionyx Pharma Series C 2022

Loading investment round...

The leading intelligence layer for the startup ecosystem. Over 25,000 AI startups, curated, scored, and agent-ready, backed by 14,000+ investors, 75,000+ people and 24,000+ funding rounds you can query in real time through our RAG API.

DR64Ahrefs DR: 64/100. Above median. Measured by Ahrefs. Median 44.·

eDR82Effective DR: 82/100. Above median. Measured by StartupHub.ai. Median 68.·

Agent94Agent Readiness: 94/100. Top 25%. Measured by StartupHub.ai. Median 41.·

Trust99Data Trust: 99/100. Top 25%. Measured by StartupHub.ai. Median 61.·

API91API & MCP Security: 91/100. Measured by StartupHub.ai.our own scores, refreshed daily

Questions or support: Help and contact

Product

Startups
Investors
Rankings
Trending
Watchlist
Pricing
Price match

Tools

Free Tools
Article to YouTube
Agent Readiness
Email Validator
API Docs
MCP Server

Company

About
Contact
AI News
Blog
How-to guides
Write for Us
Advertise

Legal

Privacy Policy
Terms
Affiliate Disclosure
security.txt
Sitemap
RSS

© 2026 StartupHub.ai. All rights reserved.

StartupHub.ai

Discover

Home
Search
Submit Profile
News
Videos
Jobs

Browse

Rankings
New Startups
Market Analysis
Comparison
Watchlist

Tools

Email Validator
DR Checker
Agent Readiness
Market Map Maker
All Free Tools

Company

Pricing
Advertise
API Docs
About
Publish Content

ABIONYX Pharma Series C

ABIONYX Pharma Series C

2015Toulouse, France

Profile section

About

ABIONYX Pharma is a next-generation biopharmaceutical company focused on developing innovative therapies for sepsis and intensive care. Their approach is based on a proprietary technology platform utilizing apoA-I.

Round details

Amount$20M

SeriesSeries C

AnnouncedJan 10, 2022

Tags

BiotechnologyFrance

Source

Round announcement

abionyx.com

Round score

55/100

Solid

A solid round with healthy fundamentals.

Round size vs peers
Smaller than the typical Series C round.

Heuristic read of round size vs peers, syndicate size, insider conviction, and investor track record. Not investment advice.

vs. Series C rounds (200)

Round size distribution16th pct

smaller Series C roundslarger

vs. Biotechnology (188)

Round size in sector52th pct

$160Kthis round: $20M$130M

ABIONYX Pharma Series C · $20M raised · (2022) | StartupHub.ai